Related Experiment Video
Updated: Aug 13, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Different calcium pools in human platelets and their role in thromboxane A2 formation
Human platelets store calcium in two distinct pools. Thapsigargin and other Ca(2+)-ATPase inhibitors reveal these pools, crucial for platelet activation and thromboxane A2 formation.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Platelet activation involves intracellular calcium increase, a critical signaling event.
- Calcium release from inositol 1,4,5-trisphosphate-sensitive stores and thromboxane A2 formation are key to platelet activation.
- Inhibitors of intracellular Ca(2+)-ATPases, like thapsigargin, can deplete these calcium stores.
Purpose of the Study:
- To investigate the distinct calcium pools within human platelets.
- To elucidate the role of Ca(2+)-ATPase inhibitors in calcium mobilization and platelet activation.
- To understand the interplay between calcium pools, thromboxane formation, and platelet signaling.
Main Methods:
- Utilized Ca(2+)-ATPase inhibitors (thapsigargin, 2,5-di-(tert-butyl)-1,4-benzohydroquinone) to study calcium transients in human platelets.
- Employed EGTA to chelate extracellular calcium and fura-2 for calcium measurements.
- Investigated the effects of thrombin and thromboxane receptor blockade on calcium release.
Main Results:
- Thapsigargin and benzohydroquinone induced different calcium transients, with benzohydroquinone showing inherent cyclooxygenase inhibition.
- Thapsigargin mobilized calcium from a thrombin-responsive store, dependent on an intact platelet self-amplification system.
- Blocking the thromboxane receptor reduced thapsigargin-induced calcium release, while thrombin could still release additional calcium.
- Thrombin pre-treatment did not prevent subsequent thapsigargin-induced calcium release, suggesting distinct pool dynamics.
Conclusions:
- Human platelets possess at least two distinct calcium pools: a rapidly releasable inositol-sensitive pool and a Ca(2+)-ATPase-sensitive pool.
- The inositol-sensitive pool is involved in initial receptor-mediated calcium release and is sensitive to thrombin.
- The Ca(2+)-ATPase-sensitive pool can be refilled and its calcium released independently of thromboxane receptor activation, but is necessary for maximal thromboxane B2 formation.
More Related Videos
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Related Concept Videos
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...